Showing 1 - 20 results of 23 for search 'Stephen Opat', query time: 0.06s
Refine Results
-
1
Zanubrutinib: past, present, and future by Constantine S. Tam, Javier L. Muñoz, John F. Seymour, Stephen Opat
Published 2023-09-01
Article -
2
Correction: Zanubrutinib: past, present, and future by Constantine S. Tam, Javier L. Muñoz, John F. Seymour, Stephen Opat
Published 2023-10-01
Article -
3
-
4
Disseminated Enteroviral Infection Associated with Obinutuzumab by Claire Dendle, Michael Gilbertson, Tony M. Korman, Vera Golder, Eric Morand, Stephen Opat
Published 2015-09-01
Article -
5
Efficacy of Zanubrutinib in the Treatment of Bing–Neel Syndrome by Jonathan Wong, Lawrence Cher, James Griffiths, Aileen Cohen, Jane Huang, Lai Wang, Gareth Gregory, Stephen Opat
Published 2018-12-01
Article -
6
-
7
COVID-19 Infection in Patients With Chronic Lymphocytic Leukemia Receiving Acalabrutinib in the Phase 3B ASSURE Study by Carsten U. Niemann, Farrukh T. Awan, Laura Fogliatto, Eugene Nikitin, Olga Samoilova, Adel Habib, Kayhan Foroutanpour, Nataliya Kuptsova-Clarkson, Stephen Opat
Published 2022-10-01
Article -
8
Real‐World Data on Lymphoma in Adolescents and Young Adults (AYA)—Report From the Lymphoma and Related Diseases Registry (LaRDR) by Evangeline Y. Wong, Cameron Wellard, Jun Yen Ng, Eliza Chung, Zoe K. McQuilten, Stephen Opat, Erica M. Wood, Dipti Talaulikar
Published 2025-02-01
Article -
9
Zanubrutinib, Alone and in Combination With Tislelizumab, for the Treatment of Richter Transformation of Chronic Lymphocytic Leukemia by Constantine Tam, Javier Munoz, Gavin Cull, Stephen Opat, Heather Allewelt, Xiaoping Zhang, Jennifer C. Stern, James Hilger, Kunthel By, Aileen Cohen, Alessandra Tedeschi
Published 2023-04-01
Article -
10
Understanding the experience, treatment preferences and goals of people living with chronic lymphocytic leukemia (CLL) in Australia by Simon Fifer, Jenni Godsell, Stephen Opat, Nada Hamad, Masa Lasica, Cecily Forsyth, Louisa Morand, Erica Smeaton, Sharon Winton, Andrea Puig, Marija McGeachie
Published 2024-07-01
Article -
11
Venous thromboembolism in primary central nervous system lymphoma during frontline chemoimmunotherapy by Hiu Lam Agnes Yuen, Alison Slocombe, Vanessa Heron, Sanjeev Chunilal, Jake Shortt, Maciej Tatarczuch, George Grigoriadis, Sushrut Patil, Gareth P. Gregory, Stephen Opat, Michael Gilbertson
Published 2020-08-01
Article -
12
Protocol for SARS-CoV-2 post-vaccine surveillance study in Australian adults and children with cancer: an observational study of safety and serological and immunological response t... by Amy Body, Elizabeth Ahern, Luxi Lal, Karen Gillett, Hesham Abdulla, Stephen Opat, Tracey O’Brien, Peter Downie, Stuart Turville, C. Mee Ling Munier, Corey Smith, C. Raina MacIntyre, Eva Segelov
Published 2022-01-01
Article -
13
Polatuzumab vedotin plus bendamustine and rituximab or obinutuzumab in relapsed/refractory follicular lymphoma: a phase Ib/II study by Christopher R. Flowers, Matthew J. Matasar, Alex F. Herrera, Mark Hertzberg, Sarit Assouline, Judit Demeter, Andrew McMillan, Amitkumar Mehta, Stephen Opat, Marek Trnňný, Lisa Musick, Jamie Hirata, Annie Yang, Laurie H. Sehn
Published 2023-09-01
Article -
14
Long‐term outcomes of second‐line versus later‐line zanubrutinib treatment in patients with relapsed/refractory mantle cell lymphoma: An updated pooled analysis by Yuqin Song, Keshu Zhou, Dehui Zou, Dengju Li, Jianda Hu, Haiyan Yang, Huilai Zhang, Jie Ji, Wei Xu, Jie Jin, Fangfang Lv, Ru Feng, Sujun Gao, Daobin Zhou, Constantine S. Tam, David Simpson, Michael Wang, Tycel J. Phillips, Stephen Opat, Cheng Fang, Shaohui Sun, Jun Zhu
Published 2023-09-01
Article -
15
Zanubrutinib monotherapy in relapsed/refractory mantle cell lymphoma: a pooled analysis of two clinical trials by Keshu Zhou, Dehui Zou, Jianfeng Zhou, Jianda Hu, Haiyan Yang, Huilai Zhang, Jie Ji, Wei Xu, Jie Jin, Fangfang Lv, Ru Feng, Sujun Gao, Daobin Zhou, Constantine S. Tam, David Simpson, Michael Wang, Tycel J. Phillips, Stephen Opat, Zhiyue Huang, Huafei Lu, Yuqin Song, Yongping Song
Published 2021-10-01
Article -
16
P1193: POLATUZUMAB, BENDAMUSTINE & RITUXIMAB (POLA-BR) EFFICACY IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA (RRDLBCL) TRIAL-INELIGIBLE PATIENTS: AN AUSTRALIAN LYMPHOMA REG... by Briony Shaw, Eliza Chung, Cameron Wellard, Edward Yoo, Rory Bennett, Callum Birks, Anna Johnston, Chan Cheah, Nada Hamad, Jock Simpson, Allison Barraclough, Matthew Ku, Nicholas Viiala, Sumita Ratnasingam, Tasman Armytage, Tara Cochrane, Geoff Chong, Denise Lee, Kate Manos, Colm Keane, Stephanie Wallwork, Stephen Opat, Eliza A Hawkes
Published 2023-08-01
Article -
17
Poor outcomes for trial‐ineligible patients receiving polatuzumab for relapsed/refractory diffuse large B‐cell lymphoma in routine care: An Australian Lymphoma and Related Diseases... by Briony Shaw, Eliza Chung, Cameron Wellard, Edward Yoo, Rory Bennett, Callum Birks, Anna Johnston, Chan Y Cheah, Nada Hamad, Jock Simpson, Allison Barraclough, Matthew Ku, Nicholas Viiala, Sumita Ratnasingam, Tasman Armytage, Tara Cochrane, Geoffrey Chong, Denise Lee, Kate Manos, Colm Keane, Stephanie Wallwork, Stephen Opat, Eliza A. Hawkes
Published 2024-04-01
Article -
18
P624: PHASE 1 STUDY OF JNJ-67856633, A FIRST-IN-HUMAN HIGHLY SELECTIVE MALT1 INHIBITOR, IN RELAPSED/REFRACTORY (R/R) B-CELL NON-HODGKIN LYMPHOMA (B-NHL) AND CHRONIC LYMPHOCYTIC LEU... by Matko Kalac, Mark Hertzberg, Chan Cheah, Vincent Ribrag, Pablo Abrisquet Acosta, Stephen Opat, Emmanuel Bachy, Loïc Ysebaert, Lihua Qiu, Shuhua Yi, Noriko Nishimura, Charlotte Lemech, Jacqueline Bussolari, Changchun Deng, Tianbao Lu, Liang Xiu, Sandy Van Hemelryck, Ulrike Philippar, Yue Guo, Virginie Soete, Isabel Soriano, Nele Fourneau, John Gerecitano, Franck Morschhauser
Published 2023-08-01
Article -
19
Impact and utility of follicular lymphoma GELF criteria in routine care: an Australasian Lymphoma Alliance study by Allison Barraclough, Shivam Agrawal, Dipti Talaulikar, Geoffrey Chong, Edward Yoo, Chan Y. Cheah, Nunzio Franco, Bianca Nguyen, Howard Mutsando, Fatima Tahir, Judith Trotman, Jing Huang, Colm Keane, Mitchel Lincoln, Tara Cochrane, Anna M. Johnston, Michael Dickinson, Stephen Opat, Zoe K. McQuilten, Erica M. Wood, Gayathri St George, Eliza A. Hawkes
Published 2024-03-01
Article -
20
Zanubrutinib monotherapy for patients with treatment-naïve chronic lymphocytic leukemia and 17p deletion by Constantine S. Tam, Tadeusz Robak, Paolo Ghia, Brad S. Kahl, Patricia Walker, Wojciech Janowski, David Simpson, Mazyar Shadman, Peter S. Ganly, Luca Laurenti, Stephen Opat, Monica Tani, Hanna Ciepluch, Emma Verner, Martin Šimkovič, Anders Österborg, Marek Trněný, Alessandra Tedeschi, Jason C. Paik, Sowmya B. Kuwahara, Shibao Feng, Vanitha Ramakrishnan, Aileen Cohen, Jane Huang, Peter Hillmen, Jennifer R. Brown
Published 2020-10-01
Article